Diamyd Medical highlights opportunity in Type 1 Diabetes prevention, adult-onset market, and upcoming Phase 3 readout PressReach · Apr 21, 2025
DAAN Biotherapeutics and GC Cell Sign Exclusive Technology Transfer Agreement for Tumor Antigen-Specific Antibody Sequence to Advance CAR-T and CAR-NK Cell Therapies PressReach · Apr 21, 2025
Shareholder Alert: Robbins LLP Informs Stockholders of the Zenas BioPharma, Inc. Class Action Lawsuit PressReach · Apr 19, 2025
Interpret Corporate Vitality Through Running, Baijiayun Spring Health Run Event successfully held PressReach · Apr 19, 2025
Akeso's Ebdarokimab ( IL - 12/IL - 23 Dual - Targeted Monoclonal Antibody) Approved in China for Moderate - to - Severe Plaque Psoriasis PressReach · Apr 19, 2025
Next Mission to Space Station Features Nanomaterials to Treat Osteoarthritis, New Materials for Lifelike Robotics, a Holographic Microscope, and More PressReach · Apr 19, 2025
New Edition of The Lancet -- Actions and Policies That Make U.S. Health Workforce Less Representative Will Harm Health and Hike Costs, warns Institute for Policy Solutions (at JHU-SON) PressReach · Apr 18, 2025
VelaVigo Announces Second Out-Licensing Deal, of a First-in-Class Bi-specific Antibody, Further Validating Its Innovative Discovery Platform and Sustainable BD+VC Business Model PressReach · Apr 18, 2025
epiq Animal Health and Interpath Global Launch Second Joint Health Product Offering - This One for Dogs PressReach · Apr 17, 2025
